Enzymes as targets for drug design:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego
Academic Press
©1989
|
| Schlagworte: | |
| Online-Zugang: | FAW01 Volltext |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | 1 Online-Ressource (xiii, 267 pages) |
| ISBN: | 0125440308 9780125440301 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042302792 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s1989 |||| o||u| ||||||eng d | ||
| 020 | |a 0125440308 |c alk. paper |9 0-12-544030-8 | ||
| 020 | |a 9780125440301 |9 978-0-12-544030-1 | ||
| 035 | |a (OCoLC)644701406 | ||
| 035 | |a (DE-599)BVBBV042302792 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615.7 |2 20 | |
| 245 | 1 | 0 | |a Enzymes as targets for drug design |c edited by Michael G. Palfreyman [and others] |
| 264 | 1 | |a San Diego |b Academic Press |c ©1989 | |
| 300 | |a 1 Online-Ressource (xiii, 267 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Drug Design / Congresses | |
| 650 | 4 | |a Enzyme Inhibitors / therapeutic use / Congresses | |
| 650 | 4 | |a Enzymes | |
| 650 | 4 | |a Médicaments / Conception | |
| 650 | 4 | |a Antienzymes | |
| 650 | 7 | |a Enzymen |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Enzyminhibitor |2 swd | |
| 650 | 7 | |a Arzneimittelentwicklung |2 swd | |
| 650 | 7 | |a Aufsatzsammlung |2 swd | |
| 650 | 7 | |a Arzneimittel |2 swd | |
| 650 | 7 | |a Drugs / Design |2 fast | |
| 650 | 7 | |a Enzyme inhibitors |2 fast | |
| 650 | 4 | |a Enzyme inhibitors | |
| 650 | 4 | |a Drugs |x Design | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Enzyminhibitor |0 (DE-588)4152479-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Palfreyman, Michael G. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780125440301 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027739784 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://www.sciencedirect.com/science/book/9780125440301 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804152882958696448 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042302792 |
| collection | ZDB-33-ESD |
| ctrlnum | (OCoLC)644701406 (DE-599)BVBBV042302792 |
| dewey-full | 615.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7 |
| dewey-search | 615.7 |
| dewey-sort | 3615.7 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02419nmm a2200649zc 4500</leader><controlfield tag="001">BV042302792</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1989 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0125440308</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-12-544030-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780125440301</subfield><subfield code="9">978-0-12-544030-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)644701406</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042302792</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enzymes as targets for drug design</subfield><subfield code="c">edited by Michael G. Palfreyman [and others]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego</subfield><subfield code="b">Academic Press</subfield><subfield code="c">©1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 267 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme Inhibitors / therapeutic use / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzymes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments / Conception</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antienzymes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Enzymen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Enzyme inhibitors</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Palfreyman, Michael G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780125440301</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027739784</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780125440301</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV042302792 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:47Z |
| institution | BVB |
| isbn | 0125440308 9780125440301 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027739784 |
| oclc_num | 644701406 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (xiii, 267 pages) |
| psigel | ZDB-33-ESD ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Enzymes as targets for drug design edited by Michael G. Palfreyman [and others] San Diego Academic Press ©1989 1 Online-Ressource (xiii, 267 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Drug Design / Congresses Enzyme Inhibitors / therapeutic use / Congresses Enzymes Médicaments / Conception Antienzymes Enzymen gtt Geneesmiddelen gtt Enzyminhibitor swd Arzneimittelentwicklung swd Aufsatzsammlung swd Arzneimittel swd Drugs / Design fast Enzyme inhibitors fast Enzyme inhibitors Drugs Design Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Enzyminhibitor (DE-588)4152479-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Enzyminhibitor (DE-588)4152479-2 s Arzneimittel (DE-588)4003115-9 s 1\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 2\p DE-604 Palfreyman, Michael G. Sonstige oth http://www.sciencedirect.com/science/book/9780125440301 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Enzymes as targets for drug design Drug Design / Congresses Enzyme Inhibitors / therapeutic use / Congresses Enzymes Médicaments / Conception Antienzymes Enzymen gtt Geneesmiddelen gtt Enzyminhibitor swd Arzneimittelentwicklung swd Aufsatzsammlung swd Arzneimittel swd Drugs / Design fast Enzyme inhibitors fast Enzyme inhibitors Drugs Design Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd Enzyminhibitor (DE-588)4152479-2 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4003115-9 (DE-588)4152479-2 (DE-588)1071861417 |
| title | Enzymes as targets for drug design |
| title_auth | Enzymes as targets for drug design |
| title_exact_search | Enzymes as targets for drug design |
| title_full | Enzymes as targets for drug design edited by Michael G. Palfreyman [and others] |
| title_fullStr | Enzymes as targets for drug design edited by Michael G. Palfreyman [and others] |
| title_full_unstemmed | Enzymes as targets for drug design edited by Michael G. Palfreyman [and others] |
| title_short | Enzymes as targets for drug design |
| title_sort | enzymes as targets for drug design |
| topic | Drug Design / Congresses Enzyme Inhibitors / therapeutic use / Congresses Enzymes Médicaments / Conception Antienzymes Enzymen gtt Geneesmiddelen gtt Enzyminhibitor swd Arzneimittelentwicklung swd Aufsatzsammlung swd Arzneimittel swd Drugs / Design fast Enzyme inhibitors fast Enzyme inhibitors Drugs Design Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd Enzyminhibitor (DE-588)4152479-2 gnd |
| topic_facet | Drug Design / Congresses Enzyme Inhibitors / therapeutic use / Congresses Enzymes Médicaments / Conception Antienzymes Enzymen Geneesmiddelen Enzyminhibitor Arzneimittelentwicklung Aufsatzsammlung Arzneimittel Drugs / Design Enzyme inhibitors Drugs Design Konferenzschrift |
| url | http://www.sciencedirect.com/science/book/9780125440301 |
| work_keys_str_mv | AT palfreymanmichaelg enzymesastargetsfordrugdesign |